Novel antibiotics for the treatment of MRSA infections: A comparison with vancomycin;Neuere antibiotika für die behandlung von MRSA-infektionen: Vergleich zur therapie mit vancomycin

Medizinische Monatsschrift fur Pharmazeuten

Volumn 29, Issue 2, 2006, Pages 56-62

  Burkhardt, Olaf ^a,b   Derendorf, Hartmut ^a,b   Welte, Tobias ^a,c  

^a University of Florida ^*

^b UNIVERSITY OF FLORIDA HEALTH   (United States)

^c HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; AZTREONAM; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; DALBAVANCIN; DALFOPRISTIN PLUS QUINUPRISTIN; DAPTOMYCIN; FOSFOMYCIN; LINEZOLID; METICILLIN; METRONIDAZOLE; ORITAVANCIN; RIFAMPICIN; TEICOPLANIN; TELAVANCIN; TIGECYCLINE; VANCOMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL INFECTION; DRUG INDICATION; DRUG STRUCTURE; ERADICATION THERAPY; GASTROINTESTINAL TOXICITY; GRAM POSITIVE BACTERIUM; HOSPITAL INFECTION; HUMAN; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MULTIDRUG RESISTANCE; MYOPATHY; NONHUMAN; REVIEW; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS INFECTION; UNSPECIFIED SIDE EFFECT; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 32144459336     PISSN: 03429601     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (1)

1. Das Literaturverzeichnis finden Sie im Internet unter www.medmopharm.de > Inhalt > 2006: Heft 2.